Aim: provide a methodological framework for the process of clinical acceptance of algorithms and software based on the artificial intelligence ("AI") technologies. The acceptance is considered as a preparation stage for the software registration as a medical product. The authors describe approaches to evaluate accuracy and efficiency of the AI algorithms for radiology. Moscow. However, reproduction and distribution, in whole or in part, by non-profit, research 
GLOSSARY
The document contains the following terms with appropriate definitions:
Medical dataset (reference data) is a collection of high-level attributes of reusable medical image datasets suitable to train, test, validate, verify, and regulate AI algorithms.
Intellectual technologies are information technologies created based on "artificial intelligence". "Artificial Intelligence" (AI) refers to systems that display intelligent behavior by analyzing their environment and taking actions -with some degree of autonomy -to achieve specific goals. AI-based systems can be purely software-based, acting in the virtual world (e.g., voice assistants, image analysis software, search engines, speech and face recognition systems) or AI can be embedded in hardware devices (e.g., advanced robots, autonomous cars, drones, or Internet of Things applications) [6] .
Mathematical model is an abstract mathematical representation of a process, device or concept; it uses a number of variables to represent inputs, outputs and internal states, and sets of equations and inequalities to describe their interaction.
Machine learning 1. A field in computer science that builds computational models that have the ability of "learning" from the data and then provide predictions. Depending on whether there is a supervisory signal, machine learning can be divided into three categories: the supervised learning, unsupervised learning, and reinforcement learning. 2. A technology for automatic learning in recognition and classification with test datasets to improve pattern detection, processing, and forecasting.
Activation threshold ("cut-off" point) is a predefined value, which triggers the algorithm (for example, the presence of a pathology).
Labelling / tagging is a standardized process of recording the pathological changes on diagnostic images to a database; the process includes lesion localization and nature, pathology reports, data extracted from unstructured text, and other information; several qualified medical specialists independently perform the process for each image or study. 
SYMBOLS AND ABBREVIATIONS
URIS
INTRODUCTION
"Artificial Intelligence" is a research field that focuses on a hardware or software modeling of human activities traditionally considered to be intellectual. AI is a part of computer sciences. New technologies are related to information technologies. The concept of "artificial intelligence", however, is not novel. An automated analysis of medical information has long-existing scientific and practical applications. In recent years, there was an explosive growth in a new generation of intelligent technologies due to significant progress in computing power and mathematics. "Artificial Intelligence" has the potential to solve many problems in medical diagnostics (decision support, morphometry, workflow automation, quality control, etc.). Before routine use, AI-based systems must undergo clinical trials to evaluate the diagnostic accuracy and obtain a status of the medical device.
Although legislative nuances may vary, in the Russian Federation medical device is defined per the Federal Law of No. 323 signed 21.11.2011. A medical device is any tool, device, equipment, materials and other products used for medicinal purposes (separately or in combination with each other), as well as accessories necessary for the use of the products mentioned before, including specialized software. Medical devices are designed for prevention, diagnosis, treatment, and medical rehabilitation, patient monitoring, medical studies, restoring, replacing, changing anatomy or physiology, preventing, or terminating a pregnancy. The functionality of a medical device is not based on pharmacological, immunological, genetic, or metabolic effects on the human body.
Any software that influences the doctor's decision-making, or provides clinically valuable information, carries a potential risk and thereby may cause harm to patients' health. Therefore, such software, including AI-based solutions, is subject to the registration as a medical device. Testing clinical effectiveness is an obligatory stage before submitting such software for registration as a medical device. These methodological guidelines form a unique approach for assessing the diagnostic efficacy of software with clinical tests. Moreover, an AI-based software can be used both independently or complementary to the other medical devices.
THE MAIN PART

Basic framework
In diagnostics, "Artificial Intelligence" is a multidisciplinary area that combines medicine, biology, mathematics, and computer science and modeling the individual components of doctors' intellectual activities (Table 1) . After an AI-based algorithm has successfully passed clinical tests, medical staff should strictly regulate its use as a decision support system. Medical professionals may use the results generated by the algorithm. "Artificial intelligence" is aimed at improving the efficiency of the healthcare system, staff productivity, reducing risks and errors, standardizing diagnostic results.
The AI-based software should undergo clinical acceptance before registration as a medical device per Article 36.1 of the Federal Law No. 323. The acceptance tests determine whether the software's accuracy and safety comply with the specifications stated by developers.
According to Article 38 of the Federal Law No. 323, a medical device is any tool, device, equipment, materials and other products used for medicinal purposes (separately or in combination with each other), as well as accessories necessary for the use of the products mentioned before, including a specialized software. Medical devices are designed for prevention, diagnosis, treatment, and medical rehabilitation, patient monitoring, medical studies, restoring, replacing, changing anatomy or physiology, preventing, or terminating a pregnancy. The functionality of a medical device is not based on pharmacological, immunological, genetic, or metabolic effects on the human body. Medical products can be considered interchangeable if they are comparable in functionality, quality, and technical characteristics, and can replace each other. • processing and transferring the data from the diagnostic medical equipment to the therapy systems;
• processing medical images (including quality, color, resolution modification, etc.);
• three-dimensional modeling (dentistry, prosthetics, orthopedics, implantology, organ, and bone prototyping, etc. [2] );
• communication between the diagnostic and therapeutic equipment;
• processing digital images. Also, it should be noted that the "software" refers to medical devices in the following cases [2] :
• processing, storing and transferring medical records;
• providing medical care via telemedicine;
• installation as part of an information system for home care;
• data processing for the electronic registration of medical equipment, medical devices used in hospitals;
• ensuring communication between patients and medical specialists, so that a patient can follow a treatment per the rules defined when using the application, and for population monitoring;
• installation as a part of a blood bank information system, single station or decentralized network.
Preliminary testing
Before an algorithm gets the status of a medical device, the "artificial intelligence" may be used for pilot projects, research works, and trials. These activities are allowed if the algorithm meets the following criteria (Annex 1). The criteria form a technical specification, creating a set of requirements for the AI-based software. Also, developers should state application purposes (Table 1) for a particular modality, use case and workflow. ______________________________ Thus, AI-based algorithms and software used in radiology belong to medical devices and must undergo clinical trials. The software can be used independently or in combination with other products (both hardware and software, for example, URIS, PACS, RIS, etc.). A preliminary deployment of an AI algorithm is possible if developers meet the methodological criteria.
Stages of clinical evaluation
Clinical acceptance tests are organized per current legislation and methodology for assessing the quality, effectiveness, and safety of medical devices. AI-based software should be evaluated on the clinical relationship (validity) between selected data and algorithm (concept, measurement, conclusion) per the intended purpose [2] .
The clinical evaluation of software that is based on "artificial intelligence" and intended for use in radiology is carried out in two stages ( Figure 1 The first stage is done by generating and analyzing diagnostic data for the intended use of software:
• a medical dataset is created;
• an automated analysis is performed, imitating a diagnostic process;
• the results are compared to the reference tagging in the dataset;
• a mathematical and statistical analysis is performed. The importance of the first stage is 90-95%. The second stage is software deployment in a routine workflow. Procedures performed with the help of AI-based algorithm are evaluated for performance and quality. That includes multiple timing studies involving several medical specialists at the varying day times and shifts and retrospective analysis of the AI-based algorithm results. The possible risks of the second stage should be minimized, providing safety for patients and their legal representatives.
The importance of the second stage is 5-10%.
A protocol of clinical acceptance should include:
• details on the medical dataset (reference data), including the state registration certificate, data type/volume, tagging information;
• information about the software installation process in the medical center;
• information on the use of computing power provided by the developer;
• information on the uninstallation process after the test completion (since the software is installed and used on the equipment before receiving a registration certificate).
In general, the software should be predesigned according to the checklist (Annex 2).
Metrics of the clinical evaluation
Analytical validation
An analytical stage consists of designing the diagnostic study and is assessed with the standard metrics.
The index test is an automated analysis of medical data by the AI-based software.
The dataset tagging, which was performed according to the methodology, is used as a reference test.
A confusion matrix is built to compare the index and reference tests. It contains the absolute values for each comparison (Table 2) . Then, the developers should select and calculate the relevant metrics (Table 3) with the reliability within 95% of the confidence interval. Various combinations of metrics can be used depending on the problem to be solved, for instance, ROC analysis and classification consistency ratio. Basic indicators, such as sensitivity, specificity, AUC should be used to define each type of "artificial intelligence" result.
Standard set of metrics
Standard metrics are used to compare the diagnostic performance of index test relative to the reference test (Table 4) . The likelihood ratio of a positive result
The mathematical relation between the probability of presence and absence of the target pathology with positive index test sensitivity / (1-specificity)
The likelihood ratio of a negative result
The mathematical relation between the probability of presence and absence of the target pathology with negative index test The likelihood ratio of a positive result should be as large as possible whereas the likelihood ratio of a negative result should be as small as possible.
Characteristic curve (ROC/FROC)
A receiver operating characteristic curve is a graphical plot illustrating the diagnostic ability of a binary classifier system as its discrimination threshold is varied. The ROC curve is created by plotting the true positive rate against the false positive rate. It is a metric of diagnostic value: area under the curve (AUC) -area bounded by (F)ROC-curve and horizontal coordinate.
Classic ROC-curve: грa diagram that illustrates the dependence of sensitivity on 1-specificity (1-specificity on the horizontal coordinate and sensitivity on the vertical coordinate).
In addition to the classic curve, we recommend calculating a ROC-curve, based on the predictive value: dependence of a positive predictive value on 1-negative predictive value (1-negative predictive value on the horizontal axis and the positive predictive value on the vertical axis). Such ROC-curve may be beneficial in some cases, as it considers the prevalence of the pathology in population. When analyzing these ROC-curves, it is necessary to determine the "cut-off" values. We recommend to use two techniques: 1) minimum distance from the upper left corner to the ROC-curve (d minimum); 2) Youden index, revealing the maximum distance from the diagonal line to the ROCcurve (Figure 2) . The "cut-off" should be defined per the research objectives. ROC-curve with a free response (FROC-curve): a diagram that illustrates the dependence of sensitivity to false positive rate (horizontal axis is for the number of false positive cases, and the vertical axis is for sensitivity).
The area under the curve (AUC) is evaluated in the range of 0-1: It is evaluated in the range of 0-1 or in percentage from 0 to 100%: Clinical validation Timing study is a method of evaluating the software's effectiveness by recording and measuring the duration of actions performed within a workflow. For example, the report turnaround time of a screening chest radiography with and without an AI-based solution.
An audit is a retrospective analysis with the goal of quality assurance. In radiology, the audit of AI-based algorithm is performed to determine the agreement with the recommended standards [4] . The audit allows assessing the quality of medical aid, including the diagnostics with and without AI; the significance of differences is determined statistically.
Reference Data Requirements
For the analytical stage of clinical tests, reference data is needed. Dataset is a structured set of diagnostic data, including diagnostic images and information on pathological changes on images; structured cases of medical care and related electronic medical documents from electronic medical records; libraries of keywords, phrases and their critical combinations, data of genetic tests, as well as combinations of various medical data, combined into a depersonalized patient (the so-called "digital twin"). If the database contains confirmed information on the final diagnosis for each case or confirmed pathological process, then it is called "verified".
The medical dataset is used for the analytical validation of an AI-based software in radiology.
A specialized medical research organization should audit the dataset. We recommend using a dataset with the state registration for clinical tests. The reference medical dataset should contain the following information: 1) state registration certificate number; 2) population characteristics (gender and age, race, geographic, etc.); depersonalization data; medical centers sourcing the database formation; 3) imaging study characteristics (anatomical region(s), modality, diagnostic device, study protocol); 4) target pathology per the International Classification of Diseases; 5) the total number of clinical cases, studies, images, reports and their distribution in diagnostic groups; 6) the normal-to-abnormal ratio ("pathology" cases can be divided into several subcategories); 7) verification data (histopathological or other "final" diagnosis); 8) tagging methodology (scientific publications, guidelines, or patents).
The reference medical database should meet the following requirements: 1) the normal-to-abnormal ratio should reflect the prevalence of the target pathology in the population; 2) several medical centers should source the medical dataset to introduce the data heterogeneity; 3) demographic, socio-economic characteristics and basic health indicators in the dataset should correspond to the population's average characteristics in the target region; 4) the proposed size of the dataset should be justified per statistical considerations, and the desired diagnostic accuracy by the main metrics indicated above.
Result registration
In the evaluation of clinical tests, the following should be considered: We recommend creating the documentation with the detailed report of data evaluation and analysis per the updated STARD 2015 checklist (Annex 2).
CONCLUSION
Some algorithms and tools based on intelligent technologies have already been successfully used in medical imaging/radiology. Further development of "artificial intelligence" should be targeted at solving specific problems.
The implementation of these recommendations allows for unifying clinical acceptance of an AI-based software in radiology. Such tests are a mandatory component for the registration of as a medical device.
Annex 1
Criteria for the admission of AI to a preliminary test operation 1 . Goals:
• The software provides a preliminary automatic analysis of medical images to improve the quality and speed of the radiology workflow;
• The software ensures a prioritization in the worklist according to the automatically revealed pathology;
• The software provides a preliminary comparative analysis of studies of a single patient at different time points (dynamic study);
• The software provides support in medical decisions;
• The software automatically prepares a draft of the radiology report based on the results of the analysis.
Certification:
• Approvals of FDA and / or CE certification (class II); actual implementations of the currently working software in medical centers: at least 2 independent institutions; more than 6 months of operation; at least 1000 successfully completed studies (confirmed by radiologists) for each task (if the software solves several tasks); • Possibility of an additional training of algorithm basing on "real world" data;
• Max. 60 seconds for processing of a single radiology study without considering the time for data transfer. When evaluating the dynamics (comparing the studies), the analysis may take more than 60 seconds, but not more than 60 seconds for one study;
• Control function ensuring the start of the automated analysis only after receiving the "status complete by radiographer" HL7 message from RIS;
• HL7 software reports on the completion of automated analysis and pathology detection for the prioritization of studies in the worklist;
• Possibility of automated search for similar studies for comparison in the PACS / RIS database;
• For each analyzed study, the software generates a declaration containing the software (algorithm) name, a list of the revealed findings (nosologies, pathological signs, deviations from norm) with indication of sensitivity and specificity for each type; the declaration is formed in DICOM SR, Overlay etc., and transmitted to PACS as a separate series; Questionnaire for the admission of software based on "artificial intelligence" / computer vision to a preliminary test operation Planned sampling size and way of it's calculating 10a
The sampling was formed sequentially, randomly or in other ways. Justification of sampling size Test methods 10b Index test, in sufficient detail to allow replication (including information on mathematical models, neural networks, machine learning methods, samplings for training and calibration used in the development process) 11 Reference test ("gold standard"), in sufficient detail to allow replication (the reference test is a reference data labelling) 12a Rationale for choosing the reference test (labelling methodology, the whole reference data base) 12b
The activation threshold ("cut-off" point) of the index test, including distinguished pre-specified result categories from exploratory. Method of determining the activation threshold: the minimum distance from the upper left corner to the ROC-curve, Youden index (depending on the study objectives) 13a
The activation threshold (threshold rules decision, "cut-off") of the reference test, including distinguished pre-specified result categories from exploratory. Method of determining the activation threshold: the minimum distance from the upper left corner to the ROC-curve, Youden index (depending on the study objectives) 13b
Whether Where the full study protocol can be accessed (including medical database information for training and calibration) 30
Sources of funding and other support; role of funders
